EGFR expression stratifies oligodendroglioma behavior

American Journal of Pathology

Volumn 179, Issue 4, 2011, Pages 1638-1644

  Horbinski, Craig ^a   Hobbs, Jonathan ^a   Cieply, Kathleen ^b   Dacic, Sanja ^b   Hamilton, Ronald L ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; RGS PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SURVIVAL; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 80053230029     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.06.020     Document Type: Article

References (30)

1. R.E. McLendon, K. Turner, K. Perkinson, and J. Rich Second messenger systems in human gliomas Arch Pathol Lab Med 131 2007 1585 1590 (Pubitemid 47606727)
2. K.J. Hatanpaa, S. Burma, D. Zhao, and A.A. Habib Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance Neoplasia 12 2010 675 684
3. C. Horbinski Practical molecular diagnostics in neuropathology: making a tough job a little easier Semin Diagn Pathol 27 2010 105 113
4. V. Martin, L. Mazzucchelli, and M. Frattini An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathology J Clin Pathol 62 2009 314 324
5. A. Perry, K.D. Aldape, D.H. George, and P.C. Burger Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma Cancer 101 2004 2318 2326 (Pubitemid 39458690)
6. M.C. Kouwenhoven, T. Gorlia, J.M. Kros, A. Ibdaih, A.A. Brandes, J.E. Bromberg, K. Mokhtari, S.G. van Duinen, J.L. Teepen, P. Wesseling, F. Vandenbos, W. Grisold, L. Sipos, R. Mirimanoff, C.J. Vecht, A. Allgeier, D. Lacombe, and M.J. van den Bent Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: a report from EORTC study 26951 Neuro Oncol 11 2009 737 746
7. M.W. Ronellenfitsch, J.P. Steinbach, and W. Wick Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives Target Oncol 5 2010 183 191
8. P.C. De Witt Hamer Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies Neuro Oncol 12 2010 304 316
9. A. Chakravarti, W. Seiferheld, X. Tu, H. Wang, H.Z. Zhang, K.K. Ang, E. Hammond, W. Curran Jr, and M. Mehta Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 62 2005 318 327 (Pubitemid 40704445)
10. L.J. Layfield, C. Willmore, S. Tripp, C. Jones, and R.L. Jensen Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors Appl Immunohistochem Mol Morphol 14 2006 91 96
11. C. Miracco, M.M. De Santi, P. Luzi, A.V. Lalinga, L. Laurini, M.C. De Nisi, G. Angeloni, M. Brogi, C. Cardone, A. Carducci, F. Arcuri, P. Tosi, G. Rubino, and L. Pirtoli In situ detection of telomeres by fluorescence in situ hybridization and telomerase activity in glioblastoma multiforme: correlation with p53 status, EGFR, c-myc, MIB1, and Topoisomerase IIalpha protein expression Int J Oncol 23 2003 1529 1535
12. A. Waha, A. Baumann, H.K. Wolf, R. Fimmers, J. Neumann, D. Kindermann, K. Astrahantseff, I. Blumcke, A. von Deimling, and U. Schlegel Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas J Neurosurg 85 1996 634 641
13. X. Muracciole, S. Romain, H. Dufour, J. Palmari, O. Chinot, L. Ouafik, F. Grisoli, D.F. Branger, and P.M. Martin PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification Int J Radiat Oncol Biol Phys 52 2002 592 598 (Pubitemid 34158718)
14. M.C. Etienne, J.L. Formento, C. Lebrun-Frenay, J. Gioanni, M. Chatel, P. Paquis, C. Bernard, A. Courdi, R.J. Bensadoun, J.P. Pignol, M. Francoual, P. Grellier, M. Frenay, and G. Milano Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome Clin Cancer Res 4 1998 2383 2390 (Pubitemid 28477903)
15. C. Horbinski, R.L. Hamilton, Y. Nikiforov, and I.F. Pollack Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas Acta Neuropathol 119 2010 641 649
16. H. Ohgaki, and P. Kleihues Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas J Neuropathol Exp Neurol 64 2005 479 489 (Pubitemid 40781150)
17. A. Guillaudeau, K. Durand, I. Pommepuy, S. Robert, A. Chaunavel, S. Lacorre, R. DeArmas, S. Bourtoumieux, M. El Demery, J.J. Moreau, and F. Labrousse Determination of EGFR status in gliomas: usefulness of immunohistochemistry and fluorescent in situ hybridization Appl Immunohistochem Mol Morphol 17 2009 220 226
18. I. Fischer, C. de la Cruz, A.L. Rivera, and K. Aldape Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH) Diagn Mol Pathol 17 2008 227 230
19. B. Kim, J.K. Myung, J.H. Seo, C.K. Park, S.H. Paek, D.G. Kim, H.W. Jung, and S.H. Park The clinicopathologic values of the molecules associated with the main pathogenesis of the glioblastoma J Neurol Sci 294 2010 112 118
20. I.F. Pollack, R.L. Hamilton, C.D. James, S.D. Finkelstein, J. Burnham, A.J. Yates, E.J. Holmes, T. Zhou, and J.L. Finlay Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort J Neurosurg 105 2006 418 424 (Pubitemid 44954773)
21. H. Ohgaki, P. Dessen, B. Jourde, S. Horstmann, T. Nishikawa, P.L. Di Patre, C. Burkhard, D. Schuler, N.M. Probst-Hensch, P.C. Maiorka, N. Baeza, P. Pisani, Y. Yonekawa, M.G. Yasargil, U.M. Lutolf, and P. Kleihues Genetic pathways to glioblastoma: a population-based study Cancer Res 64 2004 6892 6899 (Pubitemid 39330996)
22. H. Huang, Y. Okamoto, H. Yokoo, F.L. Heppner, A. Vital, M. Fevre-Montange, A. Jouvet, Y. Yonekawa, E.N. Lazaridis, P. Kleihues, and H. Ohgaki Gene expression profiling and subgroup identification of oligodendrogliomas Oncogene 23 2004 6012 6022 (Pubitemid 39093547)
23. H. Broholm, B. Bols, S. Heegaard, and O. Braendstrup Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas Clin Neuropathol 18 1999 176 180 (Pubitemid 29318056)
24. J. Reifenberger, G. Reifenberger, K. Ichimura, E.E. Schmidt, W. Wechsler, and V.P. Collins Epidermal growth factor receptor expression in oligodendroglial tumors Am J Pathol 149 1996 29 35 (Pubitemid 26230975)
25. R.E. McLendon, C.J. Wikstrand, M.R. Matthews, R. Al-Baradei, S.H. Bigner, and D.D. Bigner Glioma-associated antigen expression in oligodendroglial neoplasms: tenascin and epidermal growth factor receptor J Histochem Cytochem 48 2000 1103 1110 (Pubitemid 30640194)
26. M. Mizoguchi, R.A. Betensky, T.T. Batchelor, D.C. Bernay, D.N. Louis, and C.L. Nutt Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival J Neuropathol Exp Neurol 65 2006 1181 1188 (Pubitemid 44885942)
27. Y.-H. Zhou, K.R. Hess, V.R. Raj, L. Yu, L. Liu, A.W.K. Yung, and M.E. Linskey Establishment of prognostic models for astrocytic and oligodendroglial brain tumors with standardized quantification of marker gene expression and clinical variables Biomarker Insights 5 2010 153 168
28. C.W. Lee, C.C. Lin, W.N. Lin, K.C. Liang, S.F. Luo, C.B. Wu, S.W. Wang, and C.M. Yang TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells Am J Physiol Lung Cell Mol Physiol 292 2007 L799 L812
29. B. Tews, J. Felsberg, C. Hartmann, A. Kunitz, M. Hahn, G. Toedt, K. Neben, L. Hummerich, A. von Deimling, G. Reifenberger, and P. Lichter Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling Int J Cancer 119 2006 792 800 (Pubitemid 44051441)
30. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674